Status:
COMPLETED
Antiviral Activity of AZD7295 in HCV Carriers
Lead Sponsor:
Arrow Therapeutics
Conditions:
Hepatitis C
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
Brief Summary
PK, safety study of AZD7295 in HCV carriers
Eligibility Criteria
Inclusion
- HCV carrier
Exclusion
- concurrent medications
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2010
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT00781976
Start Date
November 1 2008
End Date
March 1 2010
Last Update
March 31 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prof Ed Gane
Auckland, New Zealand